Insiders · Profile

Ryan Jason

Director at GeneDx. Filing since 17 Oct 2022. CIK 0001585017

Company
Date
Role
Action
Shares
Amount
Of holding
27 Aug 2025
Director
Sold at will
38,072
$4.85M
26.9%
27 Aug 2025
Director
Sold at will
1,150
$149.09K
8.8%
20 Nov 2024
Director
Sold at will
15,490
$1.07M
100%
19 Nov 2024
Director
Sold at will
31,510
$2.25M
67.0%
17 Nov 2023
Executive Chairman
Bought
58,000
$89.18K
102%
16 Nov 2023
Executive Chairman
Bought
56,742
$72.19K
opened
17 Oct 2023
Executive Chairman
Sold at will
42
$133.98
0.7%
31 Dec 2022
Executive Chairman
Sold, plan not stated
73,732
$19.31K
28.0%
17 Oct 2022
Executive Chairman
Sold, plan not stated
1,281
$1.10K
7.5%
9 decisions on file.